Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Other Non-Current Liabilities (2021 - 2025)

Historic Other Non-Current Liabilities for Strata Critical Medical (SRTAW) over the last 5 years, with Q3 2025 value amounting to $18.3 million.

  • Strata Critical Medical's Other Non-Current Liabilities rose 57830.61% to $18.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.3 million, marking a year-over-year increase of 57830.61%. This contributed to the annual value of $5.8 million for FY2024, which is 1714.4% up from last year.
  • Strata Critical Medical's Other Non-Current Liabilities amounted to $18.3 million in Q3 2025, which was up 57830.61% from $3.0 million recorded in Q2 2025.
  • Strata Critical Medical's Other Non-Current Liabilities' 5-year high stood at $42.2 million during Q3 2021, with a 5-year trough of $1.5 million in Q1 2024.
  • Its 5-year average for Other Non-Current Liabilities is $11.1 million, with a median of $6.5 million in 2023.
  • Per our database at Business Quant, Strata Critical Medical's Other Non-Current Liabilities crashed by 7852.29% in 2022 and then surged by 57830.61% in 2025.
  • Over the past 5 years, Strata Critical Medical's Other Non-Current Liabilities (Quarter) stood at $31.3 million in 2021, then plummeted by 77.38% to $7.1 million in 2022, then tumbled by 30.0% to $5.0 million in 2023, then grew by 17.14% to $5.8 million in 2024, then skyrocketed by 214.39% to $18.3 million in 2025.
  • Its last three reported values are $18.3 million in Q3 2025, $3.0 million for Q2 2025, and $3.1 million during Q1 2025.